Skip to main content
. 2024 Feb 21;159(5):484–492. doi: 10.1001/jamasurg.2023.7985

Table 2. Secondary End Points by Wound Irrigation Group.

End point Treatment group, No. (%) P valuea
Polyhexanide (n = 292) Saline (n = 295) No irrigation (n = 102) Polyhexanide vs no irrigation Polyhexanide vs saline
Surgical site infection 31 (10.6) 37 (12.5) 13 (12.8) .58 .52
Type of surgical site infection .51b .70b
None 254 (87.0) 248 (84.1) 85 (83.3) NA NA
Superficial 15 (5.1) 22 (7.5) 9 (8.8) NA NA
Deep 7 (2.4) 6 (2.0) 1 (1.0) NA NA
Organ/space 9 (3.1) 9 (3.1) 3 (2.9) NA NA
Missing 7 (2.4) 10 (3.4) 4 (3.9) NA NA
Relaparotomy 27 (9.2) 31 (10.5) 15 (14.7) .12 .61
30-d Mortality 2 (0.7) 6 (2.0) 2 (2.0) .28b .29b
Noninfectious wound complications 53 (18.2) 51 (17.3) 21 (20.1) .54 .83
Seroma 12 (4.1) 11 (3.7) 3 (2.9) .77b .83
Hematoma 14 (4.8) 14 (4.8) 5 (4.9) >.99b >.99b
Delayed wound healing 19 (6.5) 17 (5.8) 6 (5.9) .85 .73
Necrosis 0 2 (0.7) 1 (1.0) .26b .16
Other 15 (5.1) 15 (5.1) 8 (7.8) .30 >.99
Duration of hospital stay, median (range), d 14.5 (4-45) 15 (5-41) 13 (5-46) .56c .23c
No. of AEs per patient, median (range) 2 (0-18) 2 (0-15) 1 (0-20) .82c .13c
No. of serious AEs per patient, median (range) 0 (0-8) 0 (0-5) 0 (0-7) .29c .52c

Abbreviations: AE, adverse event; NA, not applicable.

a

χ2 Test, unless indicated otherwise.

b

Fisher exact test.

c

Mann-Whitney U test.